FDA Supports Logical Observation Identifiers Names And Codes

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
In the May 18, 2015, Federal Register, FDA published its support for the use of Logical Observation Identifiers Names and Codes ("LOINC") in regulatory submissions to the Center for Drug Evaluation and Research...
United States Food, Drugs, Healthcare, Life Sciences

In the May 18, 2015, Federal Register, FDA published its support for the use of Logical Observation Identifiers Names and Codes ("LOINC") in regulatory submissions to the Center for Drug Evaluation and Research ("CDER") and the Center for Biologics Evaluation and Research ("CBER"). FDA encourages all applicants and sponsors to use LOINC codes for clinical test results in investigational study data to help align data standards in clinical research nationwide. Comments due June 29, 2015.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More